The role of nitric oxide (NO) in the mechanism of hemodilution-induced cerebral hyperemia is unclear. Based on findings in hypoxemia, the authors hypothesize that NO of neuronal origin contributes to an increase in velocity of eryth rocytes in the cerebral microcirculation during anemia pro duced by isovolemic hemodilution. The change in erythrocyte velocity in cerebrocortical capillaries was assessed by intravital fluorescence video microscopy. A closed cranial window was implanted over the frontoparietal cortex of barbiturate anesthetized, ventilated adult rats. Erythrocytes were labeled in vitro with fluorescein isothiocyanate and infused intravenously. and their velocity in subsurface capillaries was measured by frame-to-frame image tracking. Arterial blood was withdrawn in increments of 2 mL and replaced by serum albumin; arterial Substantial evidence supports that nitric oxide (NO) produced by the neuronal isoform of NO synthase (NOS) plays an important role in cerebral vasodilation to vari ous physiologic, pathologic, and pharmacologic stimuli, including hypercapnia (Wang et aI.
blood pressure was maintained at control level with an infusion of methoxamine. Erythrocyte velocity increased progressively, reaching 215% of baseline, as arterial hematocrit was reduced from 45% to 17%. Pretreatment of a separate group of rats with 7-nitroindazole (20 mg/kg intraperitoneally), a relatively selec tive inhibitor of neuronal NO synthase, abolished the increase in velocity at hematocrits greater than 20%, but the maximum velocity attained at the lowest hematocrit was similar to that in the control group. The results suggest that NO from neuronal source may contribute to the increase in capillary erythrocyte flow during moderate isovolemic hemodilution. Key Words: Nitric oxide-Neuronal nitric oxide synthase-Cerebral blood flow-Microcirculation-Capillaries-Anemia-Hypoxia. 1995). We recently found (Hudetz et aI., 1998 ) that acute hypoxemia-induced increases in erythrocyte flow veloc ity in the cerebral capillary bed were abolished by 7-ni troindazole (7-NI), a relatively specific inhibitor of neu ronal NOS. The significance of this finding was that it suggests a role for neuronal NO in the local regulation capillary flow. We wondered if a similar dependence of capillary erythrocyte flow on neuronal NO was present in anemia produced by isovolemic hemodilution.
The effect of hemodilution on capillary perfusion in the brain has not been directly examined. Previously, Rosenblum (1971) studied the velocity of erythrocytes in pial vessels and the velocity of plasma through intracor tical vessels of the mouse and reported significant in creases in both parameters during isovolemic anemia. Likewise, Lin et aI. (1996) demonstrated a reduction of erythrocyte and plasma transit times by isovolemic he modilution in the partially ischemic rat brain. Todd et a!. (1992) measured the effect of isovolemic hemodilution on intracortical erythrocyte and plasma volumes by ra dioactive labeling and predicted a significant decrease in microvascular hematocrit. None of these studies were based on direct observation of erythrocyte flow in cere bral capillaries.
Recently, Todd et al. (1997) examined the potential role of NO in cerebral vasodilation to anemia and hyp oxemia in a rabbit model. They conclude that NO played some role in cerebral vasodilation to hypoxemia but not to anemia. Despite the importance of this study, there are several reasons to further investigate this issue. First, the effect of NOS inhibition on cerebral capillary erythro cyte flow in anemia has not been determined. Studies of the microcirculation demonstrate that during hemodilu tion, capillary erythrocyte flow may be altered differ ently from regional blood flow because of changes in perfusion heterogeneity and plasma skimming (Rosen blum, 1987; Tyml, 1991; Pries et aI., 1992) . Second, the effect of the neuronal NOS inhibitor, 7-NI, on the he modilution response has not been investigated. Whereas endothelial NO could mediate shear-dependent vasodila tion, neuronal NO may play a principal role in the re sponse to hypoxia (Millar, 1995) . Third, the experiments by Todd et al (1997) examined the CBF response to severe hemodilution (15% hematocrit) only. We thought that the use of moderate, graded anemic stimulus could reveal the finer adjustments of erythrocyte flow in the capillary network.
The objective of this study was to determine if the neuronal NOS inhibitor, 7-NI altered the cerebral micro circulatory response to graded, isovolemic hemodilution. We hypothesized that 7-NI would attenuate the hemodi lution-induced increase in erythrocyte velocity in cere brocortical capillaries, which would suggest a role for active, neuronal NO-dependent mechanisms in the hy peremic response. To assess the hemodilution-induced changes in capillary flow directly, the study was con ducted by intravital microscopic technique using a rat closed cranial window preparation.
METHODS

Experimental preparation
The experiments were performed on nine male Sprague Dawley rats of 230 to 280 g weight. The animals were anes thetized with sodium-pentobarbital (60 mg/kg intraperitoneal Iy) and tracheotomized, and bilateral femoral arterial and ve nous lines were placed to measure arterial blood pressure, withdraw blood, and infuse drugs. Anesthesia was maintained with sodium pentobarbital infusion at 7 to 10 mg/h. The head was secured in a stereotaxic apparatus, and a closed cranial window was installed over the right parietal cortex using a technique previously described (Hudetz et aI., 1995) . The win dow was equipped with ports for superfusion with artificial cerebrospinal fluid at 37°C and for the measurement of intra cranial pressure. The latter was stabilized at 5 to 10 mm Hg. After surgery, the animals were transferred to the intravital microscope, paralyzed with gallamine (80 mg), and artificially ventilated with a mixture of 30% O2 and 70% N2. Arterial blood pressure, end-tidal CO2, and inspired oxygen concentra tions were continuously monitored (POET II, Criticare Sys-terns). The rate and volume of ventilation were adjusted to achieve an arterial Peol of approximately 35 mm Hg.
Video microscopy
Erythrocytes obtained from a donor rat were labeled in vitro with fluorescein isothiocyanate and injected intravenously in tracer quantities into the circulation of the experimental animal (Hudetz et aI., 1995) . With the use of epifluorescence and a 40x objective lens, the passage of labeled cells through intracortical capillaries 50 to 70 f,Lm below the pial surface could be visu alized in real time and video recorded. The optical magnifica tion was 125x with a field size of 300 x 400 f,Lm. Although the capillary walls themselves were not visible, capillaries could be identified by the presence of single-file erythrocyte flow (im plying vessel diameter of less than 5 f,Lm) and by the tortuous and branching pathway of moving cells. The small depth of field (less than 10 f,Lm) limited the study to capillary segments that run at right angles to the camera and are nearly parallel to the brain surface. This minimized the possibility for projection error in the measurement of flow velocity. A typical capillary segment visible in the plane of focus was 60 f,Lm long. To minimize the exposure of the preparation to light, a 50% neutral density filter was used at all times, and continuous illumination was limited to I-minute periods while the circulation was video recorded. A heat filter and a 455-nm high-pass filter were used to block infrared and ultraviolet irradiation of the tissue.
Experimental protocol
Graded isovolemic hemodilution was produced by the re peated withdrawal of 2 mL of blood, immediately replaced by the same volume of serum albumin (50 mg/mL in 0.7% NaCI, Sigma-Aldrich Co.). A IOO-f,LL sample of blood was used for hematocrit determination, and 400 f,LL of blood was used for the measurement of blood gases after each hemodilution step. To support the arterial blood pressure, the ai-agonist methox amine (Sigma-Aldrich Co.) was infused intravenously at a rate between I and IS mg/kg/h, as in prior studies (Hudetz et aI., 1998) . Intravenous a I -selective adrenergic agonists have been reported to exert no direct effect on the cerebral vasculature in vivo (Sokrab and Johansson, 1989) . The rate of infusion of methoxamine was adjusted after each hemodilution step as nec essary to maintain MABP at control level. The infusion of methoxamine usually was initiated after the third or fourth hemodilution step.
In each animal, the microcirculation was video recorded in the control state (before hemodilution) and 5 to 7 minutes after the completion of each hemodilution step. This time frame allowed us to stabilize MABP at the control level and was short enough to preserve cardiovascular stability of the preparation for the duration of the experiment. Four animals were treated with 7-NI (ICN Biomedicals, Inc.) at 20 mg/kg intraperitoneal ly, 45 minutes before the control recording. Three of the control animals were treated with peanut oil, the vehicle for 7-NI, and two received no treatment.
Data analysis
Erythrocyte velocity was measured during video playback by frame-to-frame tracking of the labeled cells using an imaging system developed in our laboratory (Hudetz et aI., 1993) . Four capillaries typically were chosen for measurement. In each cap iIlary, cell velocity was measured at 3-to 5-second intervals, yielding 15 measurements per capillary, and averaged over the I-minute recording period. With control plus five hemodilution steps performed, over 3200 velocity measurements were made. Statistical analysis for between-group comparison was per formed using multivariate analysis of variance with the type of A. C. HUDETZ ET AL. treatment (7-NI or control) as the factor and the velocity at each hemodilution step as the dependent variable. The effect of he modilution on velocity in the same treatment group was ana lyzed with repeated-measures analysis of variance followed by paired t-test. Linear regression was used to estimate the depen dence of capillary cell density on arterial hematocrit.
RESULTS
Systemic arterial physiologic parameters are displayed in Table 1 . There were no notable differences between the experimental groups except a slightly higher arterial pressure in the 7-NI-treated group (9 mm Hg, not sta tistically significant). However, all MABP values were within the physiologic range, and they were unchanged during the hemodilution protocol in both groups. All physiologic parameters were stable during the experi ments.
Average baseline velocity of erythrocytes in the con trol group was 0.73 ± 0.28 mmls (mean ± SD). Graded isovolemic hemodilution produced a consistent increase in erythrocyte velocity in every measured capillary. In the control group, a significant increase in velocity was seen with each hemodilution step. The mean velocity attained at the fifth hemodilution step was l.57 ± 0.40 mmls. The velocity-hematocrit relationship essentially was linear in this group.
In the 7 -Nl-treated group, baseline velocity was 0.50 ± 0.23 mmls, significantly lower than in the controls. This difference was consistent with the expected effect of 7-NI on resting CBF. During hemodilution, erythro cyte velocity attained a maximum of 1.51 ± 0.46 mmls, which was not different from that in the control group. However, the rise in velocity was considerably attenu ated at hemodilution steps 1 through 3 (Fig. 1 ). Further more, in the 7-NI-treated animals, the increases in ve- Hematocrit, % locity at 31 % and 27% hematocrit were small and not statistically significant at 31 % hematocrit.
To estimate the change in capillary hematocrit during hemodilution, the number of labeled erythrocytes pass ing through each capillary was counted, and lineal cell density was calculated as the cell count per cell velocity. We found that during hemodilution, lineal cell density essentially was unchanged (r = 0.19) in both the control and 7-NI-treated groups. The supply rate of erythrocytes (number of cells traversing the capillary per time) changed in parallel with erythrocyte velocity in both groups.
DISCUSSION
The objective of this study was to determine if the neuronal NOS inhibitor, 7-NI, influenced the response of erythrocyte flow velocity in cerebrocortical capillaries to graded isovolemic hemodilution. We found that 7-NI im peded the hyperemic response to moderate but not to severe hemodilution, These results suggest that NO pro duced by neuronal (type I) NOS played an important role in the erythrocyte flow response to the moderate anemic stimulus, whereas passive or NO-independent mecha nisms played the dominant role under the severe anemic condition.
The observed rise in erythrocyte flow velocity was consistent with the known hyperemic response of CBF to hemodilution. Traditionally, this response has been as signed to a decrease in blood viscosity or to active ce rebral vasodilation. Investigators who studied the effect of hemodilution on pial artery diameter found no vaso dilation (Rosenblum, 1971; Hum et aI., 1993) or vaso constriction (Muizelaar et aI., 1983; Hudak et aI., 1989) , supporting the principal role of rheologic factors. How ever, Todd et al. (1992) report an increase in microvas cular blood volume, suggesting the presence of intrace rebral vasodilation during isovolemic hemodilution. Sub sequently, Waschke et al. (1994) decreased blood viscosity by exchange transfusion with a Newtonian oxy gen carrier and saw no change in CBF. These findings suggest that active cerebrovascular adjustment as a func tion of blood oxygen saturation took place during hemo dilution.
The current results are consistent with the role of ac tive vasodilation in the cerebral hyperemic response to hemodilution. However, alternative mechanisms, includ ing blood cell-endothelial interactions in the microcircu lation, should be considered. Because arterial P02 did not fall and capillary erythrocyte flow increased, tissue hyp oxia was unlikely and could not play a role in the he modilution response. This contention is supported by Bauer et al. (1996) , who showed that EEG and high energy phosphates in the brain were preserved at arterial hematocrits as low as 6%. Direct measurements of intra cortical P02 during hemodilution would be made to con firm the absence of tissue hypoxia during isovolemic hemodilution.
Recently, Todd et ai. (1997) found that NOS inhibition did not influence the hemodilution-induced hyperemia at an arterial hematocrit of 15%. Our results are consistent with this finding and with the role of NO-independent mechanisms at low hematocrit level. However, with moderate reductions of arterial hematocrit, NO appears to play a significant role, which does not conflict with the results of Todd et ai. (1997) . Another difference between the study of Todd et ai. and ours is that we used 7-NI instead of the nonspecific NOS inhibitor, L-nitro-arginine methyl ester. Although objections to the specificity of 7-NI have been raised, the bulk of investigations suggest otherwise (Handy and Moore, 1998) . 7-Nitroindazole has been shown to considerably inhibit brain NOS cata lytic activity and cerebral vasodilation to several physi ologic stimuli (Wang et aI., 1995; Cholet et aI., 1997; Colonna et aI., 1997; Yang and Chang, 1998) . If the minor increase in MABP observed after 7-NI treatment were real, it could be caused by either peripheral or cen tral effects.
In this study, we used a relatively low dose of 7-NI (20 mg/kg) to minimize the chance for nonspecific effects. This dose was chosen based on the study by Connop et ai. (1994) , who showed that inhibition of NOS in the substantia nigra and the cerebellum was maximal (about 90%) with 20 mg/kg 7-NI. If the degree of NOS inhibi tion were less, the main conclusion of our study would be unaffected, since the role of NO in the hemodilution response would be, at worst, underestimated.
As noted in Results, resting erythrocyte velocity was lower in the 7-NI-treated group, consistent with the re moval of baseline NO and a decrease in resting CBF (Kelly et aI., 1995; Wang et aI., 1995; Cholet et aI., 1997; Okamoto et aI., 1997 a) . It may have been that a lower resting velocity contributed to the different character of the velocity response after treatment with 7-NI. How ever, this could not be the sole reason for the observed difference because (I) erythrocyte velocities were not different at the lowest hematocrits between the two groups, and (2) the statistically significant difference at moderate hemodilution prevailed after normalizing to or subtracting the respective baseline velocities in each group. We observed that baseline erythrocyte velocity after 7-NI treatment was lower than measured in our previous study (Hudetz et aI., 1998) . We believe that this difference resulted from the greater care taken to select true capillaries that exhibit the lowest erythrocyte flow rates. Another source of discrepancy could have been the independent group design of the current study.
Whether the impediment of hemodilution response af ter 7-NI was caused by specific effect on capillary flow or by a more general effect on regional CBF remains to be investigated. We found in a recent study (Hudetz et aI., 1998) that the effect of 7 -NI on capillary erythrocyte flow in acute hypoxemia was much more dramatic than the corresponding effect on regional erythrocyte flow. These findings suggest that 7-NI interfered with a local mechanism of flow regulation specific to the terminal microvascular bed. It is possible that during hemodilu tion, capillary erythrocyte flow did not strictly follow the change in CBF. Hemodilution has been implied to influ ence the microcirculation by increasing erythrocyte flow selectively in poorly perfused capillaries (Pries et aI., 1992; Tyml, 1991) . Rosenblum (1987) altered hemato crit and plasma viscosity by various means and found that erythrocytes and plasma did not have the same path lengths and influenced the velocities of erythrocyte and plasma in different ways. In this study, we found that erythrocyte density in capillaries did not change with hemodilution after 7-NI, suggesting that a postulated change in microhematocrit was not responsible for the impediment of the hemodilution response. Although lin eal cell density changed frequently in individual capil laries, no systematic trend with arterial hematocrit was apparent in either experimental group.
The site of NO's action on capillary erythrocyte ve locity is unknown. Capillaries generally are regarded un able to actively change their diameter, although a passive change in diameter with intraluminal pressure is plau sible. Detection of a change in capillary diameter was A. G. HUDETZ ET AL.
beyond the capability of our imaging technique. As a more likely scenario, terminal feed arterioles or precap illary pericytes may selectively regulate capillary flow; pericytes have been shown to relax in response to exog enous NO (Haefliger et aI., 1994) . Alternatively, NO may influence capillary flow by modulating leukocyte adhesion (Mitchell and Tyml, 1996) .
Whether NO production increased during hemodilu tion is unclear. In the absence of tissue hypoxia, the signal leading to neuronal NOS activation is elusive. En hanced production of new NOS protein can be dis counted within the time frame of our experiment. Shear induced NO production in the endothelium by type I NOS (Rosenblum and Murata, 1996) may play a role but needs confirmation. Alternatively, NO may support smooth muscle relaxation without an increase in NOS activity, by a permissive effect (Okamoto et ai, 1997a) .
In summary, the current study demonstrates that eryth rocyte velocity in cerebrocortical capillaries increases as the arterial hematocrit is reduced and that 7-NI inhibits this response at hematocrits as low as 20%. The results suggest that NO from neuronal NOS may play an im portant role in the regulation of capillary erythrocyte flow during moderate isovolemic hemodilution.
